BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260530T170000
DTEND;TZID=Australia/Sydney:20260530T170000
DTSTAMP:20260506T120835
CREATED:20260331T013448Z
LAST-MODIFIED:20260331T013448Z
UID:10000274-1780160400-1780160400@melanoma.org.au
SUMMARY:The Viertel Charitable Foundation Clinical Investigator Awards
DESCRIPTION:Establishment grants for Clinical Investigators have been initiated by the Foundation in order to stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment. Clinical Investigators are awarded a once only grant of $90\,000. \nEligible applicants will be medical graduates or graduates of other clinical disciplines who have completed both their clinical and research training which will normally be at doctoral level and are commencing their first definitive clinical position\, or have been in such a post for no more than 36 months on 1 May of the year of application. \nApplicants should be actively engaged in clinical work and pursuing health and medical research in a university clinical department\, a teaching hospital\, a clinical research unit of a research institute or in an academic general practice setting. The applications will be judged predominantly on the quality of the applicant’s track record and career achievements to date. The quality of a brief research proposal will also be taken into account. \nKey Dates\nApplications open: 6 April 2026\nApplications close: 30 May 2026 \nThe Guidelines will be available here when the round opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/the-viertel-foundation-investigator-awards/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/The-Viertel-Clinical-Investigator-Awards-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260603T170000
DTEND;TZID=Australia/Sydney:20260603T170000
DTSTAMP:20260506T120835
CREATED:20260331T013308Z
LAST-MODIFIED:20260331T013308Z
UID:10000275-1780506000-1780506000@melanoma.org.au
SUMMARY:NHMRC Postgraduate Scholarships
DESCRIPTION:The National Health and Medical Research Council (NHMRC) Postgraduate Scholarships scheme funds successful applicants to attain a research based postgraduate degree – Doctor of Philosophy (PhD) or a Research Masters Degree. \n\nIt aims to support these outstanding health and medical graduates early in their career so they can be trained to conduct research that is internationally competitive and develop a capacity for original independent research within Australia. \nThe intended outcome of the Postgraduate Scholarships scheme is increased research capacity within Australia. \nPostgraduate Scholarships may be funded by\, or in conjunction with\, other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations. \n\nKey Dates\nApplications open: 8 April 2026\nMinimum data due date: 13 May 2026\nApplications close: 3 June 2026\nProposed peer review: July/August 2026 \nThe Guidelines will be available here when the round opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-postgrad-scholarships/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Postgraduate-Scholarships-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260604T170000
DTEND;TZID=Australia/Sydney:20260604T170000
DTSTAMP:20260506T120835
CREATED:20260505T054709Z
LAST-MODIFIED:20260505T054709Z
UID:10000289-1780592400-1780592400@melanoma.org.au
SUMMARY:SNOW MEDICAL Snow Fellowship
DESCRIPTION:Snow Fellowships target emerging global research leaders that show the potential to drive\, manage and influence the next generation of health and medical innovation. The Fellowship provides these emerging leaders the independence\, funding and time to develop a bold research program\, build their research team\, and establish leadership experience. \nEach Snow Fellowship will be valued at approximately $8 million over eight years for eligible early to mid-career researchers. Fellowship funding will be available to set up and operate a research laboratory\, comprising salaries for the Snow Fellow and post doctoral researchers\, PhD student scholarship top-ups\, technical and laboratory management support\, project funds and leadership development. \nThe Snow Fellowship program supports ambitious research and high-performing teams\, and we believe that these are based on diversity\, inclusivity and gender equality. \nSnow Fellowship \nBiomedical research\nUp to $1M per year\n8 years of funding (review at year 4/5)\nMentorship\, leadership and management training support \nKey Dates \nExpression of Interest closes: 4 June 2026\nFull Application opens (via invitation): 1st week of August 2026\nFull Application closes: 1 October 2026\nInterview: early February 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/snow_medical/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/Snow-Fellowship-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260707T170000
DTEND;TZID=Australia/Sydney:20260707T170000
DTSTAMP:20260506T120835
CREATED:20260505T055547Z
LAST-MODIFIED:20260505T055547Z
UID:10000290-1783443600-1783443600@melanoma.org.au
SUMMARY:RACP Research Awards and Career Grants
DESCRIPTION:Through the RACP Foundation\, we’re able to offer financial support to Fellows and trainees pursuing careers in medical research. Over 50 different fellowships\, scholarships and grants are available annually\, totalling over $2.5 million in funding. \nCareer Development Fellowships are intended for mid-career researchers who completed their research higher degree over 7 years ago and/or researchers who are not eligible for either Research Entry Scholarship or Research Establishment Fellowships. \nResearch Establishment Fellowships are available to Fellows and Advanced Trainees who want to establish themselves in a research career. \nResearch Entry Scholarships provide stipend support only and are to assist Fellows and Advanced Trainees who are: \n\nat the start of their research careers and about to enrol in a Masters\, PhD or equivalent research higher degree\nin the 1st or 2nd full-time equivalent year of their research degree.\n\n\nKey Dates\nApplications close: 30 June 2026\nApplications close (Research Entry Scholarships): 7 July 2026\nOutcomes advised: December 2026 \nSEE WEBSITE
URL:https://melanoma.org.au/event/racp-awards-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/RACP-Awards-and-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260714T170000
DTEND;TZID=Australia/Sydney:20260714T170000
DTSTAMP:20260506T120835
CREATED:20260505T055930Z
LAST-MODIFIED:20260505T055930Z
UID:10000291-1784048400-1784048400@melanoma.org.au
SUMMARY:MRFF National Critical Research Infrastructure
DESCRIPTION:The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams. \nStream 1 – Innovation enablers\nAddress an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks\, tissue repositories\, novel platforms\, and secure health data environments to create valuable research resources. \nStream 2 – Digitisation of health care\nTranslate or implement innovative artificial intelligence technologies into health applications that: \n\nbenefit multiple health disciplines/areas\ninvolve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and\nincrease artificial intelligence workforce capacity and capability\, particularly in relation to health\, through cross-sector and interdisciplinary collaboration.\n\nStream 3 – Co-investment partnerships\nUtilise co-investment (cash only) with the research sector\, state and/or territory governments\, and industry\, in significant critical research infrastructure (e.g. facilities\, personnel and equipment): \n\nto support development of research capacity\, capability and/or effectiveness in an area of unmet medical need\, or\nto enable Australian research using new platforms\, systems and services in an area of unmet medical need.\n\nStream 4 – mRNA technology enablers\nLeverage and enhance emerging mRNA technologies\, platforms\, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need. \nGrants to fund research infrastructure projects\, up to $3 million in Streams 1\, 2 and 4\, and up to $7 million in Stream 3. \nAn application may only be submitted to one of the above four streams. Applicants must specify the stream to which they are applying in their application. \n\n\n\nKey Dates\nApplications close: 14 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-research-infrastructure/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Critical-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260722T170000
DTEND;TZID=Australia/Sydney:20260722T170000
DTSTAMP:20260506T120835
CREATED:20260505T060230Z
LAST-MODIFIED:20260505T060230Z
UID:10000292-1784739600-1784739600@melanoma.org.au
SUMMARY:MRFF BioMedTech Incubator
DESCRIPTION:The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. \nThis grant is for an eligible organisation who can establish a working incubator\, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development. \nThe 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. \nThis opportunity looks to fund suitable organisations to identify\, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential. \nThe intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers\, diagnostics\, therapeutics\, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation. \nApplicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector). \nGrants of up to $33 million to establish BioMedTech Incubators. \n\nKey Dates\nApplications close: 22 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-incubator/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Incubator-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260506T120835
CREATED:20260505T060732Z
LAST-MODIFIED:20260505T060732Z
UID:10000293-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF Genomics Health Futures
DESCRIPTION:The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \nStream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy. \nStream 2 (TCR): conduct scalable research to enhance novel gene discoveries\, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies. \nStream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease\, diabetes and other common and/or complex diseases). \nStream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer\, colorectal cancer\, prostate cancer and other common cancers) \nStream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice. \nStream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing\, portability\, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical\, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics. \nApplicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan. \nKey Dates \n\nMinimum data due date: 22 July 2026\nApplications close: 19 August 2026\nIndicative funding status: Funding anticipated to be awarded from June 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-genomics-health-futures/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-Genomics-Health-Futures600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261111T170000
DTEND;TZID=Australia/Sydney:20261111T170000
DTSTAMP:20260506T120835
CREATED:20260331T013110Z
LAST-MODIFIED:20260331T013110Z
UID:10000276-1794416400-1794416400@melanoma.org.au
SUMMARY:NHMRC Partnership Projects
DESCRIPTION:The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions\, undertake research\, interpret the findings and implement the findings into policy and practice. \n\nPartnership Projects create partnerships among decision makers\, policy makers\, managers\, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery\, organisation\, funding and access to health services. \nPartnership Projects will support collaborations\, within the Australian context\, that translate research evidence into health policy and health practice\, to improve health services and processes. \nThe objectives of the Partnership Project scheme are to: \n• Meet the need for more effective integration of research evidence into health policy and service delivery\n• Create partnerships among policy makers\, managers\, service providers and researchers\n• Provide support to answer often complex and difficult questions that policy makers\, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care\n• Be highly responsive to the priorities of government\, the community and health professionals\n• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. \n\nKey Dates for Peer Review Cycle 2:\nApplications open: 19 March 2026\nNHMRC-approved Administering Institutions waiver due: 8 July 2026\nMinimum data due: 22 July 2026\nApplications close: 5 August 2026\nPeer review meetings: 17-19 November 2026 \nKey Dates for Peer Review Cycle 3:\nApplications open: 23 July 2026\nNHMRC-approved Administering Institutions waiver due: 14 October 2026\nMinimum data due: 28 October 2026\nApplications close: 11 November 2026\nPeer review meetings: 2-4 March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-partnership-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Partnership-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR